Benjamin Li
Mar 5, 2010

Mindshare, Aegis Media, OMD and ZenithOptimedia vie for Xian-Janssen Pharmaceutical media planning account in China

BEIJING - Johnson & Johnson owned Xian-Janssen Pharmaceutical Company has called a media planning review in China.

Johnson & Johnson Daktarin Xian-Janssen Pharmaceutical
Johnson & Johnson Daktarin Xian-Janssen Pharmaceutical
Mindshare, Aegis Media, OMD and ZenithOptimedia are understood to be involved in the pitch.

According to agency sources, the account is a “good size and meaningful” and is worth an estimated US$15 million.

OMD holds the media buying account for Johnson & Johnson. The agency won the business in 2007, which also includes Shanghai Johnson & Johnson Pharmaceuticals and Johnson & Johnson Vision Care.

Motilium and Daktarin are among Xian-Janssen Pharmaceutical's main products in China.


 
Source:
Campaign China

Related Articles

Just Published

23 hours ago

Agency Report Card 2024: Ogilvy

Ogilvy APAC celebrated a strong creative year in 2024, clinching top regional honours at Cannes Lions. Yet operational headwinds, particularly in China, tested its resilience and reshaped its growth strategy.

23 hours ago

Campaign Global Agency of the Year Awards 2024: ...

Ogilvy and UM win global network of the year awards for creative and media respectively, while Special agency in New Zealand earns Asia-Pacific network of the year.

1 day ago

Apple Watch’s heart story strikes a chord in Japan

Apple’s new Japan campaign tells the real-life story of a heavy metal fan whose Apple Watch alerts help detect a life-threatening heart condition just in time.

1 day ago

2025 Cannes Contenders: RGA creatives weigh in

A ubiquitous surname, a sexually transmitted infection, the printing of memories and an animal god that helps gamers might all bring fame glory to campaigns in Cannes next week.